379 related articles for article (PubMed ID: 25459186)
1. Hematopoietic stem cell transplantation for patients with sickle cell disease: progress and future directions.
Fitzhugh CD; Abraham AA; Tisdale JF; Hsieh MM
Hematol Oncol Clin North Am; 2014 Dec; 28(6):1171-85. PubMed ID: 25459186
[TBL] [Abstract][Full Text] [Related]
2. Alternative Donor/Unrelated Donor Transplants for the β-Thalassemia and Sickle Cell Disease.
Fitzhugh CD; Abraham A; Hsieh MM
Adv Exp Med Biol; 2017; 1013():123-153. PubMed ID: 29127679
[TBL] [Abstract][Full Text] [Related]
3. Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study.
Eapen M; Brazauskas R; Walters MC; Bernaudin F; Bo-Subait K; Fitzhugh CD; Hankins JS; Kanter J; Meerpohl JJ; Bolaños-Meade J; Panepinto JA; Rondelli D; Shenoy S; Williamson J; Woolford TL; Gluckman E; Wagner JE; Tisdale JF
Lancet Haematol; 2019 Nov; 6(11):e585-e596. PubMed ID: 31495699
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic hematopoietic stem cell transplantation from sibling and unrelated donors in pediatric patients with sickle cell disease-A single center experience.
Kogel F; Hakimeh D; Sodani P; Lang P; Kühl JS; Hundsdoerfer P; Künkele A; Eggert A; Oevermann L; Schulte JH
Pediatr Transplant; 2021 Mar; 25(2):e13892. PubMed ID: 33098344
[TBL] [Abstract][Full Text] [Related]
5. Unrelated Umbilical Cord Blood Transplantation for Sickle Cell Disease Following Reduced-Intensity Conditioning: Results of a Phase I Trial.
Abraham A; Cluster A; Jacobsohn D; Delgado D; Hulbert ML; Kukadiya D; Murray L; Shenoy S
Biol Blood Marrow Transplant; 2017 Sep; 23(9):1587-1592. PubMed ID: 28578010
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic transplantation using haploidentical donor vs. unrelated cord blood donor in pediatric patients: a single-center retrospective study.
González-Vicent M; Molina B; Andión M; Sevilla J; Ramirez M; Pérez A; Díaz MA
Eur J Haematol; 2011 Jul; 87(1):46-53. PubMed ID: 21692851
[TBL] [Abstract][Full Text] [Related]
7. Alternative donor hematopoietic stem cell transplantation for sickle cell disease in Europe.
Gluckman E; Cappelli B; Scigliuolo GM; De la Fuente J; Corbacioglu S
Hematol Oncol Stem Cell Ther; 2020 Dec; 13(4):181-188. PubMed ID: 32201153
[TBL] [Abstract][Full Text] [Related]
8. Is there a best graft source of transplantation in acute myeloid leukemia?
Ballen KK
Best Pract Res Clin Haematol; 2015; 28(2-3):147-54. PubMed ID: 26590772
[TBL] [Abstract][Full Text] [Related]
9. Haploidentical hematopoietic cell transplantation for adult acute myeloid leukemia: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Lee CJ; Savani BN; Mohty M; Labopin M; Ruggeri A; Schmid C; Baron F; Esteve J; Gorin NC; Giebel S; Ciceri F; Nagler A
Haematologica; 2017 Nov; 102(11):1810-1822. PubMed ID: 28883081
[TBL] [Abstract][Full Text] [Related]
10. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts.
Raiola AM; Dominietto A; di Grazia C; Lamparelli T; Gualandi F; Ibatici A; Bregante S; Van Lint MT; Varaldo R; Ghiso A; Gobbi M; Carella AM; Signori A; Galaverna F; Bacigalupo A
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1573-9. PubMed ID: 24910379
[TBL] [Abstract][Full Text] [Related]
11. Umbilical cord blood as a hematopoietic stem cell source in transplantation for pediatric sickle cell disease: current challenges and strategies.
Malhotra M; Shenoy S
Transfus Apher Sci; 2022 Oct; 61(5):103554. PubMed ID: 36096996
[TBL] [Abstract][Full Text] [Related]
12. Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease.
Wiebking V; Hütker S; Schmid I; Immler S; Feuchtinger T; Albert MH
Ann Hematol; 2017 Aug; 96(8):1373-1377. PubMed ID: 28573314
[TBL] [Abstract][Full Text] [Related]
13. When there is no match, the game is not over: Alternative donor options for hematopoietic stem cell transplantation in sickle cell disease.
Joseph JJ; Abraham AA; Fitzhugh CD
Semin Hematol; 2018 Apr; 55(2):94-101. PubMed ID: 29958565
[TBL] [Abstract][Full Text] [Related]
14. Outcomes from unrelated donor hematopoietic stem cell transplantation.
Perez LE
Cancer Control; 2011 Oct; 18(4):216-21. PubMed ID: 21976240
[TBL] [Abstract][Full Text] [Related]
15. Unrelated cord blood compared with haploidentical grafts in patients with hematological malignancies.
El-Cheikh J; Crocchiolo R; Furst S; Bramanti S; Sarina B; Granata A; Vai A; Lemarie C; Faucher C; Mohty B; Harbi S; Bouabdallah R; Vey N; Santoro A; Chabannon C; Castagna L; Blaise D
Cancer; 2015 Jun; 121(11):1809-16. PubMed ID: 25649994
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic cellular gene therapy for hemoglobinopathies.
Gaziev J; Lucarelli G
Hematol Oncol Clin North Am; 2010 Dec; 24(6):1145-63. PubMed ID: 21075285
[TBL] [Abstract][Full Text] [Related]
17. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
18. Alternative donors hematopoietic stem cells transplantation for adults with acute myeloid leukemia: Umbilical cord blood or haploidentical donors?
Ruggeri A; Ciceri F; Gluckman E; Labopin M; Rocha V;
Best Pract Res Clin Haematol; 2010 Jun; 23(2):207-16. PubMed ID: 20837332
[TBL] [Abstract][Full Text] [Related]
19. Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).
Kamani NR; Walters MC; Carter S; Aquino V; Brochstein JA; Chaudhury S; Eapen M; Freed BM; Grimley M; Levine JE; Logan B; Moore T; Panepinto J; Parikh S; Pulsipher MA; Sande J; Schultz KR; Spellman S; Shenoy S
Biol Blood Marrow Transplant; 2012 Aug; 18(8):1265-72. PubMed ID: 22343376
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cell transplantation and cellular therapy in sickle cell disease: where are we now?
Tanhehco YC; Bhatia M
Curr Opin Hematol; 2019 Nov; 26(6):448-452. PubMed ID: 31483336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
